Pantarhei Bioscience B.V.
Records under this name other than the patents Pantarhei Bioscience B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Pantarhei Bioscience B.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,034,854 | Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy Formerly held In force · High confidence | In force | High confidence | |
| US 7,732,430 | Drug Delivery System Comprising a Tetrahydroxilated Estrogen for Use in Hormonal Contraception Formerly held In force · High confidence | In force | High confidence | |
| US 8,236,785 | Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,367,647 | Treatment of meconium aspiration syndrome with estrogens Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,987,240 | Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,518,923 | Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,801,627 | Sampler Lapsed on the fee record Ended Aug 12, 2026 · High confidence | Lapsed on the fee record | Ended Aug 12, 2026 | High confidence |
| US 9,040,509 | Method of treating human skin and a skin care composition for use in such a method Formerly held Term ended Term ended Jan 24, 2026 · From the USPTO record | Term ended | Term ended Jan 24, 2026 | From the USPTO record |
| US 7,871,995 | Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception Formerly held Term ended Term ended Oct 7, 2025 · From the USPTO record | Term ended | Term ended Oct 7, 2025 | From the USPTO record |
| US 8,048,869 | Pharmaceutical composition for use in hormone replacement therapy Formerly held Term ended Term ended May 14, 2025 · From the USPTO record | Term ended | Term ended May 14, 2025 | From the USPTO record |